Drug middlemen are pushing patients to pay for more expensive drugs, lawmakers findByBruce GilPublishedJuly 23, 2024
More people without diabetes are using weight loss drugs like Ozempic, study saysByBruce GilPublishedJuly 23, 2024
Hims & Hers has a 'long future' in selling off-brand Ozempic, former Novo Nordisk executive saysByBruce GilPublishedJuly 22, 2024
Lawmakers propose healthcare cybersecurity bill to tackle growing threatsByBruce GilPublishedJuly 19, 2024
The CrowdStrike global tech outage hit hospitals around the world and delayed surgeriesByBruce GilPublishedJuly 19, 2024
The CrowdStrike global tech outage took news outlets off the air for hoursByBruce GilUpdatedFriday 10:15AM
A new weight loss pill, Ozempic boosts protein sales, J&J's cancer drug: Pharma news roundupByBruce GilPublishedJuly 19, 2024
The TV networks and streamers that got the most Emmy nominations — and the leastByBruce GilUpdatedThursday 12:36PM
A new weight loss pill has Novo Nordisk and Eli Lilly shares fallingByBruce GilPublishedJuly 17, 2024
Johnson & Johnson's cancer drug Darzalex could replace Stelara as its best-sellerByBruce GilUpdatedJuly 17, 2024
Warner Bros. Discovery 'is not working' and should make some big changes, analysts sayByBruce GilPublishedJuly 16, 2024
Netflix reports earnings this week. Here's what analysts are watchingByBruce GilPublishedJuly 16, 2024
The next big thing in the weight loss drug boom has little to do with losing weightByBruce GilPublishedJuly 15, 2024